NCT04676048View on ClinicalTrials.gov

ASC618 Gene Therapy in Hemophilia A Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2026

Conditions

Hemophilia A

Interventions

BIOLOGICAL

ASC618

ASC618 will be given as a single IV infusion

Trial Locations (1)

72202

RECRUITING

Arkansas Children's Hospital, Little Rock

Sponsors

Lead Sponsor

ASC Therapeutics

All Listed Sponsors

lead

ASC Therapeutics

INDUSTRY